Head to Head Contrast: Aspyra (OTCMKTS:APYI) vs. Hims & Hers Health (NYSE:HIMS)

Aspyra (OTCMKTS:APYI) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares Aspyra and Hims & Hers Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspyra	N/A	N/A	N/A	N/A	N/A
Hims & Hers Health	$2.35 billion	2.86	$128.37 million	($0.09)	-322.40

Hims & Hers Health has higher revenue and earnings than Aspyra.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Aspyra and Hims & Hers Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspyra	0	0	0	0	0.00
Hims & Hers Health	2	11	4	0	2.12

Hims & Hers Health has a consensus price target of $28.70, suggesting a potential downside of 1.09%. Given Hims & Hers Health’s stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Aspyra.

Volatility and Risk

Aspyra has a beta of -0.06, indicating that its stock price is 106% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the S&P 500.

Profitability

This table compares Aspyra and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aspyra	N/A	N/A	N/A
Hims & Hers Health	-0.56%	6.10%	1.52%

Insider and Institutional Ownership

63.5% of Hims & Hers Health shares are owned by institutional investors. 23.9% of Aspyra shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Hims & Hers Health beats Aspyra on 8 of the 10 factors compared between the two stocks.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.